C5a receptor signalling in dendritic cells controls the development of maladaptive Th2 and Th17 immunity in experimental allergic asthma

Mucosal Immunology

Volumn 6, Issue 4, 2013, Pages 807-825

  Schmudde, I ^a   Strover H A ^a   Vollbrandt, T ^a   Konig P ^a   Karsten, C M ^a   Laumonnier, Y ^a   Kohl J ^a,b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; BIM PROTEIN; CD11B ANTIGEN; COMPLEMENT COMPONENT C5A RECEPTOR; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; OVALBUMIN; PROTEIN BCL 2;

ADOPTIVE TRANSFER; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EOSINOPHILIA; LYMPHOCYTE DIFFERENTIATION; MOUSE; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; SUPPRESSOR CELL; TH17 CELL; TH2 CELL;

EID: 84879350303     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.119     Document Type: Article

References (50)

1. Lambrecht, B.N. & Hammad, H. Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology. Annu. Rev. Immunol. 30, 243-270 (2012).
2. Raymond, M. et al. Selective control of SIRP-alpha-positive airway dendritic cell trafficking through CD47 is critical for the development of T(H)2-mediated allergic inflammation. J. Allergy Clin. Immunol. 124, 1333-1342 (2009).
3. Furuhashi, K. et al. Mouse lung CD103 + and CD11bhigh dendritic cells preferentially induce distinct CD4+ T-cell responses. Am. J. Respir. Cell Mol. Biol. 46, 165-172 (2012).
4. Nakano, H. et al. Pulmonary CD103(+) dendritic cells prime Th2 responses to inhaled allergens. Mucosal Immunol. 5, 53-65 (2012).
5. De Heer, H.J. et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200, 89-98 (2004).
6. Kö hl, J. et al. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J. Clin. Invest. 116, 783-796 (2006).
7. Zhang, X. & Köhl, J. A complex role for complement in allergic asthma. Expert Rev. Clin. Immunol. 6, 269-277 (2010).
8. Krug, N., Tschernig, T., Erpenbeck, V.J., Hohlfeld, J.M. & Kö hl, J. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am. J. Respir. Crit. Care Med. 164, 1841-1843 (2001).
9. Lajoie, S. et al. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat. Immunol. 11, 928-935 (2010).
10. Karp, C.L. et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat. Immunol. 1, 221-226 (2000).
11. Drouin, S.M., Sinha, M., Sfyroera, G., Lambris, J.D. & Wetsel, R.A. A protective role for the fifth complement component (c5) in allergic airway disease. Am. J Respir. Crit. Care Med. 173, 852-857 (2006).
12. Baelder, R. et al. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation. J. Immunol. 174, 783-789 (2005).
13. Abe, M. et al. Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats. J. Immunol. 167, 4651-4660 (2001).
14. Zhang, X. et al. A protective role for C5a in the development of allergic asthma associated with altered levels of B7-H1 and B7-DC on plasmacytoid dendritic cells. J. Immunol. 182, 5123-5130 (2009).
15. Weaver, D.J. Jr et al. C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells. Eur. J. Immunol. 40, 710-721 (2010).
16. Burgdorf, S., Kautz, A., Bohnert, V., Knolle, P.A. & Kurts, C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 Tcell activation. Science 316, 612-616 (2007).
17. Lambrecht, B.N. et al. Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J. Clin. Invest. 106, 551-559 (2000).
18. Sung, S., Rose, C.E. & Fu, S.M. Intratracheal priming with ovalbumin-and ovalbumin 323-339 peptide-pulsed dendritic cells induces airway hyper-responsiveness, lung eosinophilia, goblet cell hyperplasia, and inflammation. J. Immunol. 166, 1261-1271 (2001).
19. Raymond, M., Van, V.Q., Wakahara, K., Rubio, M. & Sarfati, M. Lung dendritic cells induce T(H)17 cells that produce T(H)2 cytokines, express GATA-3, and promote airway inflammation. J. Allergy Clin. Immunol. 128, 192-201 e196 (2011).
20. Strainic, M.G. etal. Locally produced complement fragmentsC5a and C3a provide both costimulatory and survival signals to naive CD4 + T cells. Immunity 28, 425-435 2008).
21. Peng, Q. et al. Dendritic cell function in allostimulation is modulated by C5aR signaling. J. Immunol. 183, 6058-6068 (2009).
22. Bouillet, P. & O'Reilly, L.A. CD95, BIM and T cell homeostasis. Nat. Rev. Immunol. 9, 514-519 (2009).
23. Erlacher, M. et al. Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J. Exp. Med. 203, 2939-2951 (2006).
24. Gabrilovich, D.I. & Nagaraj, S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162-174 (2009).
25. Youn, J.I., Nagaraj, S., Collazo, M. & Gabrilovich, D.I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181, 5791-5802 (2008).
26. Marigo, I., Dolcetti, L., Serafini, P., Zanovello, P. & Bronte, V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol. Rev. 222, 162-179 (2008).
27. Greifenberg, V., Ribechini, E., Rossner, S. & Lutz, M.B. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development. Eur. J. Immunol. 39, 2865-2876 (2009).
28. Arora, M. et al. TLR4/MyD88-induced CD11b+Gr-1 int F4/80 + non-migratory myeloid cells suppress Th2 effector functioninthe lung.Mucosal Immunol. 3, 578-593 (2010).
29. Hawlisch, H. et al. C5a negatively regulates toll-like receptor 4-induced immune responses. Immunity 22, 415-426 (2005).
30. Fang, C., Zhang, X., Miwa, T. & Song, W.C. Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production. Blood 114, 1005-1015 (2009).
31. McKinley, L. et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol. 181, 4089-4097 (2008).
32. Fei, M. et al. TNF-alpha from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infection. Proc.Natl. Acad. Sci. USA108, 5360-5365 (2011).
33. Krishnamoorthy, N. et al. Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat. Med. 14, 565-573 (2008).
34. Shushakova, N. et al. C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J. Clin. Invest. 110, 1823-1830 (2002).
35. Drouin, S.M. et al. Expression of the complement anaphylatoxin C3a and C5a receptorson bronchial epithelial and smooth muscle cells inmodels of sepsis and asthma. J. Immunol. 166, 2025-2032 (2001).
36. Zhang, X. et al. A critical role for C5L2 in the pathogenesis of experimental allergic asthma. J. Immunol. 185, 6741-6752 (2010).
37. Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V.K. IL-17 and Th17 cells.Annu. Rev. Immunol. 27, 485-517 (2009).
38. Hashimoto, M. et al. Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J. Exp. Med. 207, 1135-1143 (2010).
39. Liu, B. et al. Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J. Transl. Med. 9, 1-12 (2011).
40. Li, K. et al. Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood 112, 5084-5094 (2008).
41. Sallusto, F., Cella, M., Danieli, C. & Lanzavecchia, A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromo-lecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389-400 (1995).
42. Menges, M. et al. IL-4 supports the generation of a dendritic cell subset from murine bone marrow with altered endocytosis capacity. J. Leukoc. Biol. 77, 535-543 (2005).
43. Yamane, H., Zhu, J. & Paul, W.E. Independent roles for IL-2 and GATA-3 in stimulating naive CD4 + T cells to generate a Th2-inducing cytokine environment. J. Exp. Med. 202, 793-804 (2005).
44. Lalli, P.N. et al. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis 153. Blood 112, 1759-1766 (2008).
45. Deshane, J. et al. Free radical-producing myeloid-derived regulatory cells: potent activators and suppressors of lung inflammation and airway hyperresponsiveness. Mucosal Immunol. 4, 503-518 (2011).
46. Rossner, S. et al. Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro. Eur. J. Immunol. 35, 3533-3544 (2005).
47. Markiewski, M.M. et al. Modulation of the antitumor immune response by complement. Nat. Immunol. 9, 1225-1235 (2008).
48. Wills-Karp, M. et al. Interleukin-13: central mediator of allergic asthma. Science 282, 2258-2261 (1998).
49. Daffern, P.J., Pfeifer, P.H., Ember, J.A. & Hugli, T.E. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondarytoeosinophil activation. J. Exp. Med. 181, 2119-2127 (1995).
50. Hildeman, D.A.etal. ActivatedTcelldeathinvivomediated by proapoptotic bcl-2 family member bim. Immunity 16, 759-767 2002).